Language: English, Korean
Gender: Male
WCM Physician (What is this?)
Leukemia
520 East 70th Street , Starr Pavilion, 3rd Floor
New York, NY 10021
Fax
(646) 962-0115
Call
(646) 962-2700
Richard T. Silver, M.D. Myeloproliferative Neoplasms (MPN) Center
520 East 70th Street , Starr Pavilion, 3rd Floor
New York, NY 10021
Call
(646) 962-2727

Personal Statement

It is a privilege to take care of patients with blood disorders. Each patient is different, each blood disorder is different, and I believe treatment approaches should be tailored to the individual patient. At the Weill Cornell Leukemia Program, we work as a team to recommend treatment options for each patient. We have a number of novel therapeutic options for blood disorders, and we work closely with the scientists at the leukemia program to study each and every patients’ disorder to tailor treatments. Treatment for blood disorders is a unique journey, and I am privileged to be a part of the journey!

 

Specialties & Expertise

Specialties

  • Hematology/Oncology
  • Hematology

Expertise

  • MPN (Myeloproliferative Neoplasm)
  • Myelodysplasia
  • ALL (Acute Lymphoblastic Leukemia)
  • Chronic Myelogenous Leukemia
  • Aplastic Anemia
  • MDS (Myelodysplastic Syndrome)
  • Myeloproliferative Neoplasm
  • Immunotherapy

Insurance Plans Accepted

The following represents most of the managed care plans accepted by this physician. If your insurance carrier does not appear here please contact the physician’s office as they may have individual contracts not included on this site.

* indicates this physician is no longer accepting new patients with this insurance plan.

  • AETNA - PPO
  • AETNA - Medicare
  • AETNA - HMO
  • Aetna - Weill Cornell - POS
  • Affinity Access
  • Affinity Health Plan
  • Amida Care
  • Blue Priority Network
  • CIGNA
  • Emblem (HIP) Medicare Essential Network
  • Emblem Select Care
  • Empire Blue Cross/Blue Shield - PPO
  • Empire Blue Cross/Blue Shield - Pathway X
  • Empire Blue Cross/Blue Shield - Pathway X Enhanced
  • Empire Blue Cross/Blue Shield - Mediblue (Senior)
  • Empire Blue Cross/Blue Shield - HMO
  • Empire Blue Cross/Blue Shield - EPO
  • Empire Empire Blue Cross/Blue Shield HealthPlus
  • Empire Empire Blue Cross/Blue Shield HealthPlus - CHP
  • Fidelis Care
  • GHI - CBP
  • Health First
  • Health Insurance Plan of NY (HIP) - Medicaid
  • Health Insurance Plan of NY (HIP) - Medicare
  • Health Insurance Plan of NY (HIP)
  • Medicaid
  • Medicare
  • Oxford Health Plans - Medicare Advantage
  • Oxford Health Plans - Metro/Core/Charter
  • Oxford Health Plans - Freedom
  • Oxford Health Plans - Liberty
  • Rockefeller University - CoreSource
  • UHC Compass
  • United Empire
  • United Health Care - Medicare
  • United Health Care
  • United Health Care - Community Plan
  • VNSNY CHOICE - Medicare
  • VNSNY CHOICE - HMO
  • WellCare Health Plans
  • WellCare Health Plans

Qualifications

Board Certifications

  • Internal Medicine
  • Hematology
  • Medical Oncology

Clinical & Academic Positions

Assistant Attending Physician
NewYork-Presbyterian Hospital

Assistant Professor of Medicine
Weill Cornell Medical College, Cornell University

Education & Training

  • M.D., University of Miami School of Medicine, 2007
  • B.A., M.S., University of Pennsylvania, 2003

Biography

Sangmin Lee, MD, is an Assistant Professor of Medicine at Weill Cornell Medical College and Assistant Attending Physician at the NewYork-Presbyterian Hospital. 

After obtaining a BA/MS as a Vagelos Scholar in Molecular Life Sciences at the University of Pennsylvania in 2003, Dr. Lee received his MD from the University of Miami in 2007. Following his internal medicine residency at the University of Alabama at Birmingham, he completed his fellowship in hematology and oncology at the New York Presbyterian Hospital/Columbia University Medical Center from 2010-2013 where he focused on epigenetics of myelodysplastic syndromes (MDS) under Drs. Azra Raza and Benjamin Tycko. In July 2013, Dr. Lee was recruited to serve in the Leukemia Program in the Division of Hematology & Medical Oncology.  At Weill Cornell, he has served as an Edward P. Evans Fellow in the multi-institutional MDS Clinical Research Consortium, focusing on development of clinical and translational research programs in MDS, as well as other hematologic malignancies. He is currently the principal investigator on clinical trials investigating new therapeutic approaches in elderly AML patients, and is an investigator on a number of clinical trials for MDS, AML, and other myeloproliferative neoplams. He is the principal investigator for translational studies focusing on characterization of mutational and epigenetic profiling of MDS and AML, in collaboration with scientists at Weill Cornell Medicine.

Dr. Lee has publications in the Clinical Cancer Research, and Journal of Blood Medicine, among others. He is a member of the American Society of Clinical Oncology, the American Society of Hematology, and the American Association for Cancer Research.